Explore approved biosimilar medicines
| # | Medicine | Status | Active Substance | Therapeutic Area | Developer | Published Date |
|---|---|---|---|---|---|---|
| 61 | Acvybra | Authorised | denosumab | Bone Resorption;Osteoporosis;Osteoporosis, Postmenopausal | Reddy Holding GmbH | 19-09-2025 |
| 62 | Fymskina | Authorised | ustekinumab | Crohn Disease;Psoriasis;Arthritis, Psoriatic | Formycon AG | 26-07-2024 |
| 63 | Ogivri | Authorised | trastuzumab | Stomach Neoplasms;Breast Neoplasms | Biosimilar Collaborations Ireland Limited | 15-09-2017 |
| 64 | Osqay | Authorised | denosumab | Bone Resorption | Theramex Ireland Limited | 14-11-2025 |
| 65 | Semglee | Authorised | insulin glargine | Diabetes Mellitus | Biosimilar Collaborations Ireland Limited | 03-04-2018 |
| 66 | Fulphila | Authorised | pegfilgrastim | Biosimilar Collaborations Ireland Limited | 21-09-2018 | |
| 67 | Hulio | Authorised | adalimumab | Hidradenitis Suppurativa;Psoriasis;Uveitis;Arthritis, Rheumatoid;Spondylitis, Ankylosing;Crohn Disease;Colitis, Ulcerative;Arthritis, Psoriatic | Biosimilar Collaborations Ireland Limited | 17-09-2018 |
| 68 | Epysqli | Authorised | Eculizumab | Hemoglobinuria, Paroxysmal | Samsung Bioepis NL B.V. | 27-03-2023 |
| 69 | Wezenla | Authorised | ustekinumab | Psoriasis;Arthritis, Psoriatic;Crohn Disease | Amgen Technology (Ireland) UC | 26-04-2024 |
| 70 | Inflectra | Authorised | infliximab | Arthritis, Psoriatic;Spondylitis, Ankylosing;Colitis, Ulcerative;Psoriasis;Crohn Disease;Arthritis, Rheumatoid | Pfizer Europe MA EEIG | 30-07-2018 |
Ready to transform your strategic intelligence? Let's talk
Get latest pharmaceutical insights, blogs, and strategic updates directly in your inbox.